Fibulin-2: A Novel Biomarker for Differentiating Grade II from Grade I Meningiomas

There is an unmet need for the identification of biomarkers to aid in the diagnosis, clinical management, prognosis and follow-up of meningiomas. There is currently no consensus on the optimum management of WHO grade II meningiomas. In this study, we identified the calcium binding extracellular matr...

Descripción completa

Detalles Bibliográficos
Autores principales: Sofela, Agbolahan A., Hilton, David A., Ammoun, Sylwia, Baiz, Daniele, Adams, Claire L., Ercolano, Emanuela, Jenkinson, Michael D., Kurian, Kathreena M., Teo, Mario, Whitfield, Peter C., Sahm, Felix, Hanemann, C. Oliver
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7827565/
https://www.ncbi.nlm.nih.gov/pubmed/33429944
http://dx.doi.org/10.3390/ijms22020560

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7827565/
https://www.ncbi.nlm.nih.gov/pubmed/33429944
http://dx.doi.org/10.3390/ijms22020560

Ejemplares similares